Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
67°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Compass Pathways plc
Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
April 22, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
March 26, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression
March 18, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to Participate in Stifel Virtual CNS Forum
March 11, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights
February 27, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference
February 25, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025
February 18, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 05, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer
January 21, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways Announces Pricing of Underwritten Offering
January 10, 2025
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)
December 18, 2024
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to Participate in December Investor Conferences
November 25, 2024
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
October 31, 2024
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
October 24, 2024
From
Compass Pathways plc
Via
Business Wire
Tickers
CMPS
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.